Dexamethasone/phenytoin interactions: Neurooncological concerns

Swiss Medical Weekly

Volumn 132, Issue 29-30, 2002, Pages 425-426

  Rüegg, Stephan ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; ETIRACETAM; GABAPENTIN; PHENYTOIN; VALPROIC ACID;

ATAXIA; BRAIN TUMOR; CANCER PREVENTION; CEREBELLUM ATROPHY; DRUG METABOLISM; HUMAN; INTENSIVE CARE; LETTER; NYSTAGMUS; PATIENT MONITORING; PROTEIN BINDING; SEIZURE; SKIN MANIFESTATION; SOMNOLENCE;

EID: 0037183371     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (12)

1. Debrunner J, Schmid C, Schneemann M. Falsely positive dexamethasone suppression test in a patient tretated with phenytoin to prevent seizures due to nocardia brain abscesses. Swiss Med Wkly 2002;132:267.
2. Jubiz W, Meikle AW, Levinson RA, Mizutani S, West CD, Tyler FH. Effect of diphenylhydantoin on the metabolism of dexamethasone. N Engl J Med 1970;283:11-4.
3. Lawson LA, Blouin RA, Smith RB, Rapp RP, Young AB. Phenytoin-dexamethasone interaction: A previously unreported observation. Surg Neurol 1981;16:23-4.
4. Wong DD, Longenecker RG, Liepman M, Baker S, LaVergne M. Phenytoin-dexamethasone: A possible drug-drug interaction. JAMA 1985;254:2062-3.
5. Lackner TE. Interaction of dexamethasone with phenytoin. Pharmacotherapy 1991;11:344-7.
6. Ghosh C, Lazarus HM, Hewlett JS, Creger RJ. Fluctuation of serum phenytoin concentrations during autologous bone marrow transplant for primary central nervous system tumours. J Neurooncol 1992;12:25-32.
7. Recuenco I, Espinosa E, García B, Carcas A. Effect of dexamethasone on the decrease of serum phenytoin concentrations. Ann Pharmacother 1995;29:935.
8. Masur H, Elger CE, Ludolph AC, Galanski M. Cerebellar atrophy following acute intoxication with phenytoin. Neurology 1989;39:432-3.
9. Kuruvilla T, Bharucha NE. Cerebellar atrophy after acute phenytoin intoxication. Epilepsia 1997;38:500-2.
10. Relling MV, Pui CH, Sandlund JT, Rivera GK, Hancock ML, Boyett JM, et al. Adverse effect of anticonvulsants on efficacy of chemotherapy for acute lymphoblastic leukaemia. Lancet 2000;356:285-90.
11. Chamberlain MC. Salvage chemotherapy with CPT-11 for recurrent glioblastoma multiforme. J Neurooncol 2002;56:183-8.
12. Glantz MJ, Cole BF. Forsyth PA, Recht LD, Wen PY, Chamberlain MC, et al. Practice parameter: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000;54:1886-93.